Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Haug

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Journal of Affective Disorders|November 1, 1994
Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcomeG Ulrich, H J Haug, E Fähndrich
Biological Psychiatry|September 1, 1991
Alfred Hoche and the elimination of the unitK Kräuchi, H J Haug, P Graw
Acta Psychiatrica Scandinavica. Supplementum|March 23, 2001
Actigraphy to measure day structure as a therapeutic variable in the treatment of schizophrenic patientsH J Haug, A Wirz-Justice, W Rössler
Pharmacopsychiatry|November 1, 1988
Comparison between types of diurnal variations as determined by global assessment and daily recordings of moodR D Steiglitz, H J Haug, E Fähndrich
Schizophrenia Bulletin|October 13, 2001
Disturbed circadian rest-activity cycles in schizophrenia patients: an effect of drugs?A Wirz-Justice, H J Haug, C Cajochen
Psychopathology|March 1, 1997
Dissociative symptoms in schizophrenic patients with positive and negative symptomsC Spitzer, H J Haug, H J Freyberger
Der Nervenarzt|January 1, 1995
[Suicidal behavior of depressed patients at inpatient admission]H J Haug, B Ahrens, R D Stieglitz
Deutsche Medizinische Wochenschrift (1946)|November 8, 1991
[Imipramine in sleep apnea syndrome]H Meyer-Madaus, H J Haug, C Kessler
Journal of Neural Transmission|January 1, 1987
[3H] UK-14,304, a new agonist ligand of alpha 2-adrenoceptors: a comparative study with human and rat tissueH Rommelspacher, S Strauss, E Fähndrich, et al.
Psychiatry Research|August 1, 1988
Sleep deprivation and imipramine binding sites in depressed patients and healthy subjectsH J Haug, E Fähndrich, S Strauss, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal of Affective Disorders|November 1, 1994
Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcomeG Ulrich, H J Haug, E Fähndrich
Biological Psychiatry|September 1, 1991
Alfred Hoche and the elimination of the unitK Kräuchi, H J Haug, P Graw
Acta Psychiatrica Scandinavica. Supplementum|March 23, 2001
Actigraphy to measure day structure as a therapeutic variable in the treatment of schizophrenic patientsH J Haug, A Wirz-Justice, W Rössler
Pharmacopsychiatry|November 1, 1988
Comparison between types of diurnal variations as determined by global assessment and daily recordings of moodR D Steiglitz, H J Haug, E Fähndrich
Schizophrenia Bulletin|October 13, 2001
Disturbed circadian rest-activity cycles in schizophrenia patients: an effect of drugs?A Wirz-Justice, H J Haug, C Cajochen
Psychopathology|March 1, 1997
Dissociative symptoms in schizophrenic patients with positive and negative symptomsC Spitzer, H J Haug, H J Freyberger
Der Nervenarzt|January 1, 1995
[Suicidal behavior of depressed patients at inpatient admission]H J Haug, B Ahrens, R D Stieglitz
Deutsche Medizinische Wochenschrift (1946)|November 8, 1991
[Imipramine in sleep apnea syndrome]H Meyer-Madaus, H J Haug, C Kessler
Journal of Neural Transmission|January 1, 1987
[3H] UK-14,304, a new agonist ligand of alpha 2-adrenoceptors: a comparative study with human and rat tissueH Rommelspacher, S Strauss, E Fähndrich, et al.
Psychiatry Research|August 1, 1988
Sleep deprivation and imipramine binding sites in depressed patients and healthy subjectsH J Haug, E Fähndrich, S Strauss, et al.
Pageof 5